Lipanthyl 145 Mg 145 mg FC tablets
PDF Leaflet Revision Date: 12 March 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct treatment for severe hypertriglyceridaemia and diabetic retinopathy in type 2 diabetes.
Dosage (summary)
1 tablet (145 mg) daily; no adjustment for elderly unless renal impairment.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Oral anticoagulants
- Cyclosporin
- HMG-CoA reductase inhibitors
Contraindications
- Hypersensitivity
- Hepatic insufficiency
- Severe renal insufficiency
- Gallbladder disease
Common side effects
- Gastrointestinal disorders
- Headache
- Muscle disorders
- Increased transaminases
Counselling Points
- Take with or without food
- Monitor lipid levels
- Report muscle pain or weakness
Serious warnings
- Risk of pancreatitis
- Muscle toxicity
- Monitor liver function
Important Disclaimer
The Lipanthyl 145 Mg 145 mg FC tablets professional information leaflet below is the property of Abbott Laboratories Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
